Clinical Trial Update: First-in-human Study of SAR443765 in Healthy Participants and in Asthmatic Participants [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study of SAR443765 completed in healthy and asthmatic participants, sponsored by Sanofi.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SAR443765 (SAR443765)

Snippet

Sponsor: Sanofi | Conditions: Asthma | Phase 1 | Status: COMPLETED